Verhaagen Group

We investigate ways to promote repair of the injured nervous system with the eventual goal of translating the results to patients with brain or spinal cord and peripheral nerve injury.

This laboratory performs basic and translational research with the aim to advance the field of restorative neuroscience and neurology. We focus on the cellular and molecular mechanisms that underlie degeneration, regeneration and plasticity of the central and peripheral nervous system. A significant portion of research is dedicated to the identification of novel genes and molecular pathways that affect the capacity of the nervous system to regenerate. Genomics, bioinformatics and high-throughput functional screening are key components of our research strategy and gene therapy based on advanced viral vector technology is applied to validate the therapeutic efficacy of molecular targets in clinically relevant animal models of neurodegeneration and repair. The ultimate goal of the Laboratory for Neuroregeneration is to develop novel therapeutic strategies to promote regeneration and plasticity of injured axons.


Verhaagen Group

Simone M Crivelli, Qian Luo, Jo A A Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard Bode, Sandra den Hoedt, Barbara Hobo, Anna-Lena Scheithauer, Jochen Walter, Monique T Mulder, Christopher Exley, Matthew Mold, Michelle M Mielke, Helga E De Vries, Kristiaan Wouters, Daniel L A van den Hove, Dusan Berkes, María Dolores Ledesma, Joost Verhaagen, Mario Losen, Erhard Bieberich, Pilar Martinez-Martinez CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease Alzheimer's Research & Therapy 13 (2021) 45 Download

All publications